TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Asker Healthcare Group AB ( (SE:ASKER) ).
Asker Healthcare Group reported a 9% increase in net sales for Q2 2025, driven by organic growth and strategic acquisitions, despite negative exchange rate impacts. The company signed four acquisition agreements in the quarter, enhancing its market presence and product offerings, and maintained stable operational performance, aiming for continued growth in the fragmented European medtech market.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK100.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group AB operates in the healthcare industry, offering a broad portfolio of medical products and solutions. The company focuses on mobility and personal assistive equipment in Europe, aiming to support the development of healthcare across the continent.
Average Trading Volume: 410,340
Current Market Cap: SEK38.29B
For a thorough assessment of ASKER stock, go to TipRanks’ Stock Analysis page.